5/18
Coronavirus Research
COVID mortality age patterns changed significantly during pandemic
Between March 2020 and October 2021, death rates from the virus decreased for those 80 and older and increased for those 25 to 54, results that held across racial and ethnic groups.
DNA analysis finds links between severe COVID and other conditions
Through analyzing human DNA samples in a large biobank, Penn Medicine researchers found associations between genetic variants with severe COVID and conditions involving blood clots and respiratory issues.
A Wharton initiative championing global change
The Ideas for Action Wharton undergraduate student club is a joint initiative with the Zicklin Center for Business Ethics Research to engage youth around the world in developing solutions to global challenges.
COVID-19 turned everything upside down. What has Penn Medicine’s innovation team learned?
To many in health care—including those in Penn Medicine’s Center for Health Care Innovation—the COVID-19 pandemic is a crisis from which to find the next great learning opportunity.
From a pandemic, scientific insights poised to impact more than just COVID-19
Pivoting to study SARS-CoV-2, many scientists on campus have launched new research projects that address the challenges of the pandemic but also prepare us to confront future challenges.
Belief in vaccination misinformation predicts attitudes toward vaccinating children
The survey data come from the fifth wave of the Annenberg Science Knowledge survey, a nationally representative sample of U.S. adults empaneled by the Annenberg Public Policy Center in April 2021 to track attitudes and behavior in the pandemic.
How to safeguard your sleep from insomnia over COVID-19 worry
Penn Medicine research have tips for helping insomnia, which has seen an increase throughout the pandemic. It’s not just the disease—worrying about COVID has contributed to lack of sleep.
Six takeaways from two years of online learning
As two full years of this explosion in virtual learning approaches, Penn GSE associate professor and director of the Penn Center for Learning Analytics Ryan Baker shares some thoughts on best practices, and which practices should be avoided.
COVID in a cat
A new report led by Elizabeth Lennon of the School of Veterinary Medicine and colleagues has confirmed what is believed to be the first published account of the delta variant of SARS-CoV-2 in a house cat.
SARS-CoV-2 is moving between humans and wildlife around the U.S.
In humans the pandemic is showing signs of ebbing. In white-tailed deer and other wildlife, however, infections appear widespread.
In the News
The mRNA miracle workers
Nobel laureates Katalin Karikó and Drew Weissman of the Perelman School of Medicine appear on “Sunday Morning” to discuss their careers, their mRNA research, and the COVID-19 vaccines.
FULL STORY →
Review of COVID death stats finds likely undercount in official numbers
A paper co-authored by Penn researchers found that COVID-19 deaths in the U.S. were likely undercounted in official statistics during the first 30 months of the pandemic.
FULL STORY →
The Franklin Institute honors nine scientists and engineers on its 200th anniversary
Katalin Karikó and Drew Weissman of the Perelman School of Medicine are noted for receiving awards from the Franklin Institute and subsequently being honored with a Nobel Prize.
FULL STORY →
You should still get the COVID-19 vaccine. The Nobel Prize winner who helped discover it explains why
Drew Weissman of the Perelman School of Medicine, who won the Nobel Prize along with Katalin Karikó, discusses the backlash against vaccinations and whether to receive the latest COVID vaccine.
FULL STORY →
Long COVID brain fog may originate in a surprising place, say scientists
A study by Christoph Thaiss and Maayan Levy of the Perelman School of Medicine and colleagues finds that long COVID’s neurological symptoms, like brain fog, memory loss, and fatigue, may stem from serotonin reduction.
FULL STORY →
Long COVID research is in its ‘most hopeful’ phase yet
A study by Christoph Thaiss and Maayan Levy of the Perelman School of Medicine and colleagues suggests that serotonin could be a target for long COVID treatment.
FULL STORY →